REMINDER ADS FOR DRUGS WITH BLACK BOX WARNINGS SHOULD BE ALLOWED BY FDA, AHP COUNSEL TELLS DTC HEARING; UPJOHN LAUNCHES CAVERJECT DTC CAMPAIGN
Executive Summary
FDA should delete its prohibition on broadcast reminder advertising for drugs that carry boxed warnings in labeling, Nancy Buc of the D.C. law firm Buc, Levitt & Beardsley told FDA's hearing on direct-to- consumer promotion Oct. 18.